| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +83.33% | +12.21% | -0.67% | +12.89% | +12.63% | — |
| 14d | 6 | +83.33% | +7.85% | -0.37% | +8.22% | +4.95% | — |
| 30d | 6 | +33.33% | -4.49% | -0.12% | -4.36% | -13.97% | — |
| 60d | 6 | +33.33% | +0.43% | +0.75% | -0.32% | -11.72% | — |
| 90d | 6 | +33.33% | +9.21% | -1.80% | +11.01% | -25.41% | — |
| 180d | 6 | +33.33% | -18.05% | +0.50% | -18.55% | -32.97% | — |
| 1y | 6 | +66.67% | +67.00% | +8.86% | +58.14% | +11.86% | — |
| 2y | 6(3 pending) | +0.00% | -70.95% | +7.13% | -78.09% | -73.18% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 230,000 | — | — | 230,000 | Feb 4, 2026 | Feb 5, 2026 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE Chief Chemistry Officer | 100,000 | $0.69 | $69.3K | 480,123 | Mar 25, 2025 | Mar 27, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Feb 4, 2025 | Feb 5, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE Chief Chemistry Officer | 60,000 | $1.37 | $82.0K | 377,623 | Dec 23, 2024 | Dec 26, 2024 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE Chief Chemistry Officer | 3,075 | $1.15 | $3.5K | 317,623 | Dec 20, 2024 | Dec 26, 2024 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 135,000 | — | — | 135,000 | Feb 7, 2023 | Feb 9, 2023 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | SALE EVP, Head of Chemistry | 36,062 | — | — | 50,397 | Apr 1, 2022 | Apr 4, 2022 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE EVP, Head of Chemistry | 36,062 | $1.89 | $68.2K | 304,442 | Mar 31, 2022 | Apr 4, 2022 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Feb 15, 2022 | Feb 17, 2022 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE EVP, Head of Chemistry | 4,000 | $11.60 | $46.4K | 268,380 | Dec 14, 2021 | Dec 15, 2021 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE EVP, Head of Chemistry | 4,000 | $12.12 | $48.5K | 264,380 | Dec 13, 2021 | Dec 15, 2021 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 95,000 | — | — | 95,000 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE EVP, Head of Chemistry | 1,000 | $19.00 | $19.0K | 260,380 | Sep 29, 2020 | Sep 29, 2020 ↗ | View → |